Outcomes and potential impact of a virtual hands-on training program on MRI staging confidence and performance in rectal cancer.

Autor: El Khababi N; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands., Beets-Tan RGH; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands., Tissier R; Biostatistics Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lahaye MJ; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands., Maas M; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands., Curvo-Semedo L; Department of Radiology, Centro Hospitalar E Universitario de Coimbra EPE, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Dresen RC; Department of Radiology, University Hospitals Leuven, Leuven, Belgium., van Griethuysen JJM; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands.; Department of Radiology, UMC Utrecht, Utrecht, The Netherlands., Nougaret S; Medical Imaging Department, Montpellier Cancer Institute, Montpellier Cancer Research Institute (U1194), University of Montpellier, Montpellier, France., Beets GL; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands.; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Triest B; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Taylor SA; Department of Radiology, University College London Hospitals Biomedical Research Centre, London, UK., Lambregts DMJ; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1106 BE, Amsterdam, The Netherlands. d.lambregts@nki.nl.; GROW School for oncology and reproduction, University of Maastricht, Maastricht, The Netherlands. d.lambregts@nki.nl.

Publikováno v: European radiology [Eur Radiol] 2024 Mar; Vol. 34 (3), pp. 1746-1754. Date of Electronic Publication: 2023 Aug 30.

Intra-individual qualitative and quantitative comparison of [ ⁶⁸ Ga]Ga-DOTATATE PET/CT and PET/MRI.

Autor: Lens G; Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium., Ahmadi Bidakhvidi N; Nuclear Medicine, University Hospitals Leuven, Leuven, BelgiumNuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Vandecaveye V; Radiology, University Hospitals Leuven, Leuven, Belgium., Grauwels S; Radiology, Isala Hospitals, Zwolle, The Netherlands., Laenen A; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium., Deckers W; Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium., Peeters R; Radiology, University Hospitals Leuven, Leuven, Belgium., Dresen RC; Radiology, University Hospitals Leuven, Leuven, Belgium., Dekervel J; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Verslype C; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Nackaerts K; Respiratory Oncology, University Hospitals Leuven, Leuven, Belgium., Clement PM; General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Van Cutsem E; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Koole M; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Goffin K; Nuclear Medicine, University Hospitals Leuven, Leuven, BelgiumNuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Van Laere K; Nuclear Medicine, University Hospitals Leuven, Leuven, BelgiumNuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Deroose CM; Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Herestraat 49, 3000 Leuven, Flanders, Belgium.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Oct 24; Vol. 15, pp. 17588359231189133. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).

Sense and nonsense of yT-staging on MRI after chemoradiotherapy in rectal cancer.

Autor: El Khababi N; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; GROW School for Oncology and Reproduction, University of Maastricht, Maastricht, The Netherlands., Beets-Tan RGH; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; GROW School for Oncology and Reproduction, University of Maastricht, Maastricht, The Netherlands., Tissier R; Biostatistics Unit, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lahaye MJ; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; GROW School for Oncology and Reproduction, University of Maastricht, Maastricht, The Netherlands., Maas M; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; GROW School for Oncology and Reproduction, University of Maastricht, Maastricht, The Netherlands., Curvo-Semedo L; Department of Radiology, Centro Hospitalar e Universitario de Coimbra EPE, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Dresen RC; Department of Radiology, University Hospitals Leuven, Leuven, Belgium., Nougaret S; Medical Imaging Department, Montpellier Cancer Institute, Montpellier Cancer Research Institute (U1194), University of Montpellier, Montpellier, France., Beets GL; GROW School for Oncology and Reproduction, University of Maastricht, Maastricht, The Netherlands.; Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lambregts DMJ; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; GROW School for Oncology and Reproduction, University of Maastricht, Maastricht, The Netherlands.

Publikováno v: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland [Colorectal Dis] 2023 Sep; Vol. 25 (9), pp. 1878-1887. Date of Electronic Publication: 2023 Aug 06.

Early Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumors.

Autor: Vandecaveye V; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Dresen RC; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Pauwels E; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Van Binnebeek S; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Vanslembrouck R; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Baete K; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Mottaghy FM; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Clement PM; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Nackaerts K; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Van Cutsem E; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Verslype C; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., De Keyzer F; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.)., Deroose CM; From the Departments of Radiology (V.V., R.C.D., R.V., F.D.K.), Nuclear Medicine (E.P., K.B., C.M.D.), Medical Oncology (P.M.C.), Pulmonology/Respiratory Oncology (K.N.), and Digestive Oncology (E.V.C., C.V.), University Hospitals Leuven, Herestraat 49, Leuven, Belgium; Department of Translational MRI, Imaging and Pathology (V.V., R.C.D.), Department of Nuclear Medicine and Molecular Imaging, Imaging and Pathology (E.P., C.M.D.), and Department of Oncology (P.M.C.), KU Leuven, Leuven, Belgium; Department of Nuclear Medicine, AZ Jan Portaels, Vilvoorde, Belgium (S.V.B.); Department of Nuclear Medicine, Imelda Ziekenhuis, Bonheiden, Belgium (S.V.B.); Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany (F.M.M.); and Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands (F.M.M.).

Publikováno v: Radiology. Imaging cancer [Radiol Imaging Cancer] 2022 May; Vol. 4 (3), pp. e210095.

Intra-Arterial Therapies for Liver Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.

Autor: Aarts BM; Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.aarts@nki.nl.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands. b.aarts@nki.nl., Muñoz FMG; Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Interventional Radiology, Hospital Clinic Universitari de Barcelona, Carrer de Villarroel 170, 08036, Barcelona, Spain., Wildiers H; General Medical Oncology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium., Dezentjé VO; Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Baetens TR; Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schats W; Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Lopez-Yurda M; Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dresen RC; Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium., Wit-van der Veen BJ; Nuclear Medicine, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Deroose CM; Nuclear Medicine, Department of Imaging and Pathology, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Herestraat 49, 3000, Leuven, Belgium., Maleux G; Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium., Beets-Tan RGH; Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands., Klompenhouwer EG; Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Publikováno v: Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2021 Dec; Vol. 44 (12), pp. 1868-1882. Date of Electronic Publication: 2021 Jul 28.